ORLYNVAH (PROBENECID; SULOPENEM ETZADROXIL) — FDA Approval NDA213972 (ITERUM THERAP)
ORLYNVAH (PROBENECID; SULOPENEM ETZADROXIL) — FDA Approval NDA213972 (ITERUM THERAP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ORLYNVAH; Active ingredients: PROBENECID; SULOPENEM ETZADROXIL; Application number: NDA213972.
| Brand name | ORLYNVAH |
|---|---|
| Active ingredients | PROBENECID; SULOPENEM ETZADROXIL |
| Application number | NDA213972 |
| Sponsor | ITERUM THERAP |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20241025 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →